Gene · 2202
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes. | J Hepatol | 2023 | 37572794 | PubTator, text mining | PubMed |
| Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis. | BMC Urol | 2023 | 37563710 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development. | J Hum Genet | 2023 | 37537391 | PubTator, text mining | PubMed |
| Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma. | PLoS One | 2023 | 37535570 | PubTator, text mining | PubMed |
| Serum Proteomic Profiling in Patients with Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 37533772 | PubTator, text mining | PubMed |
| Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. | J Hematol Oncol | 2023 | 37533128 | PubTator, text mining | PubMed |
| A rare optineurin mutation in an Indian family with coexistence of JOAG and PCG. | Indian J Ophthalmol | 2023 | 37530275 | PubTator, text mining | PubMed |
| M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC. | BMC Med Genomics | 2023 | 37528384 | PubTator, text mining | PubMed |
| A Systematic Review on the Role of Matrix Metalloproteinases in the Pathogenesis of Inguinal Hernias. | Biomolecules | 2023 | 37509159 | PubTator, text mining | PubMed |
| Human Patient-Derived Brain Tumor Models to Recapitulate Ependymoma Tumor Vasculature. | Bioengineering (Basel) | 2023 | 37508868 | PubTator, text mining | PubMed |
| The role of cancer-associated fibroblasts in breast cancer metastasis. | Front Oncol | 2023 | 37496657 | PubTator, text mining | PubMed |
| Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. | Front Mol Biosci | 2023 | 37469703 | PubTator, text mining | PubMed |
| Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies. | Front Oncol | 2023 | 37469419 | PubTator, text mining | PubMed |
| Extracellular Vesicle Size Reveals Cargo Specific to Coagulation and Inflammation in Pediatric and Adult Sickle Cell Disease. | Clin Appl Thromb Hemost | 2023 | 37469147 | PubTator, text mining | PubMed |
| Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway. | Sci Rep | 2023 | 37468568 | PubTator, text mining | PubMed |
| Serum proteome profiles in patients treated with targeted temperature management after out-of-hospital cardiac arrest. | Intensive Care Med Exp | 2023 | 37455296 | PubTator, text mining | PubMed |
| Integration of Transcriptome and MicroRNA Profile Analysis of iMSCs Defines Their Rejuvenated State and Conveys Them into a Novel Resource for Cell Therapy in Osteoarthritis. | Cells | 2023 | 37443790 | PubTator, text mining | PubMed |
| A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer. | Front Oncol | 2023 | 37441420 | PubTator, text mining | PubMed |
| Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo. | Sci Rep | 2023 | 37429930 | PubTator, text mining | PubMed |
| EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells. | Cell Mol Biol Lett | 2023 | 37420173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2202/papers?page=11